Xia Wang1, Chaoqun Bu#1, Gang Tian#1, Zeliu Du1, Yu Jiang1, Na Zhao1, Chanjuan Yu1, Yuedong Han*1, Jianguang He1, Xiuzheng Yue2, and Zhiwei Shen2
1Xi'an Gaoxin Hospital, Xi'an, China, 2Philips Healthcare, Beijing, China
Synopsis
The
application of amide proton transfer (APT) weighted imaging in molecular
imaging of craniocerebral tumors has been relatively mature, but rarely reports
on renal tumors. This study conducted a preliminary comparative analysis of clear
cell renal cell carcinoma (ccRCC) and healthy adult renal APT imaging. The APTw values 6.40(6.26~7.75)%
of tumor foci in the ccRCC group was significantly higher than that
of healthy adult renal (2.05±0.24) %The preliminary results indicate that APT
technology has potential clinical application value in the diagnosis of ccRCC.
Synopsis:
The
application of amide proton transfer (APT) weighted imaging in molecular
imaging of craniocerebral tumors has been relatively mature, but rarely reports
on renal tumors. This study conducted a preliminary comparative analysis of clear
cell renal cell carcinoma (ccRCC) and healthy adult renal APT imaging. The APTw values 6.40(6.26~7.75)%
of tumor foci in the ccRCC group was significantly higher than that
of healthy adult renal (2.05±0.24) %.The preliminary results indicate that APT
technology has potential clinical application value in the diagnosis of ccRCC.
Introduction:
As a new non-invasive MRI molecular imaging technology, amide
proton transfer (APT)-weighted (APTw) imaging can indirectly reflect the
proliferation and protein metabolism of tissues and lesions from the
perspective of metabolism. It has been initially applied in the diagnosis of
urinary diseases, such as prostate cancer [1], cervical cancer [2] and ovarian
disease [3]. Due to technical reasons, there are few reports on its application
in renal diseases. Based on the good reproducibility of APTw imaging of the renal
of healthy adults in the early stage, this study preliminarily explored the
application value of APTw imaging in renal tumors.
Methods:
Seven cases (age range
from 34 to 66 years, 48.8 ±12.4, 5 males) with pathologically confirmed ccRCC
were included as the ccRCC group; 27 healthy volunteers (age range from 24 to 46
years, 30±8.9, 10 males) served as a control group. Both the ccRCC group and
the control group underwent intermittent end-respiratory breath-holding renal 3D-APTw
imaging on a 3.0T MR scanner (Ingenia CX, Philips Healthcare). APTw imaging was
performed using a saturation pulse with duration of 2s and strength of 2µT. According to the
Likert Scale scoring method for APTw image quality evaluation (Table 1), lower
scores (1 or 2) were not included in the APTw values measurement. APTw images were
analyzed independently by three radiologists with 3-, 6- and 10-years’ experience,
blinded to each other's measurements. Three
regions of interest (ROI) were placed on the right kidney in APTw image of ccRCC or control group (Table 1). All ROIs avoid blood vessels and
artifacts. A ROI was manually placed by each observer on the location of the lesion in ccRCC group or
random measurement of right kidney in control group according to the APTw
imaging, and its APTw value was measured. The intraclass correlation
coefficient (ICC) was used to evaluate the consistency of the three observers.
A non-parametric test was used to compare the difference of APTw values
between the ccRCC group and the control group.
Results:
According to Likert scale scoring
result, 6 cases were excluded due to a small lesion and poor image quality (1 in
ccRCC group and 5 in control group). APTw values measured in
the ccRCC group and control group by three observers were well consistent
(ICC>0.75) (Table 3 and Table 4).
The APTw values measured for the ccRCC group 6.40 (6.26~7.75) %
were significantly higher than that of control group (2.05±0.24) % (Figure 1), and the difference
was statistically significant (z=-3.675, P<0.001)
(Table 4).
Discussion:
ccRCC is the most common malignant tumor of the kidney. The tumor cell
density is high, which increases the production of protein and polypeptide
substances, accelerates the rate of water proton-amide proton transfer, and
increases the APTw value [4]. As the degree of tumor malignancy increases, the
nuclear atypia increases, which can induce the interaction between the
macromolecular D sub-substances and the hydrophobic cell membrane, thereby
promoting the release of proteins and peptides and causing the tumor APTw value
to increase [5]. In addition, studies have reported that the proteins and
peptides released in the process of tissue necrosis of malignant tumors also
promote the rate of amide proton transfer [6]. ccRCC is prone to hyaloid degeneration and
cystic necrosis. Among the 6 cases of ccRCC in this group, there are four cases
had definite necrosis of tumor tissue. It is speculated that the above reasons
may be the reason for the higher APTw values of this group of tumor tissues,
and it is necessary to continuously increase the inclusion of the ccRCC group for in-depth analysis.
Conclusion:
Preliminary results show the feasibility of APTw imaging of
intermittent end-respiratory breath-holding in healthy adult kidney and ccRCC. At the same time, it is found that the
APTw value of ccRCC is significantly higher than that of normal renal parenchyma.
Therefore, APTw imaging has potential clinical value in the diagnosis of renal
tumors.
Acknowledgements
NoReferences
1.Jia G,
Abaza R, Williams JD, et al. Amide proton transfer MR imaging of prostate
cancer: a preliminary study[J]. J Magneason Imaging, 2011,
33(3): 647-654. DOI:10.1002/jmri.22480.
2. Meng N,
Wang X, Sun J, et al. Application of the amide proton transfer-weighted imaging
and diffusion kurtosis imaging in the study of cervical cancer[J]. Eur Radiol,
2020, 30(10): 5758-5767.
3. Ishimatsu
K, Nishie A, Takayama Y, et al. Amide proton transfer imaging for
differentiating benign ovarian cystic lesions: Potential of first time
right[J]. European Journal of Radiology, 2019, 120: 108656.
4. Nishie A, Takayama Y, Asayama Y, et
al. Amide proton transfer imaging can predict tumor grade in rectal cancer[J].
Magneason
Imaging, 2018, 51: 96-103.
5.Tang Y,
Dundamadappa SK, Thangasamy S, et al. Correlation of apparent diffusion
coefficient with Ki-67 proliferation index in grading meningioma[J]. AJR Am J
Roentgenol, 2014, 202(6): 1303-1308.
6.Togao O, Hiwatashi A, Yamashita
K, et al. Grading diffuse gliomas without intense contrast enhancement by amide
proton transfer MR imaging: comparisons with diffusion- and perfusion-weighted
imaging[J]. Eur Radiol, 2017, 27(2): 578-588.